Adverse events · people with stroke and urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Children and adolescents with obesity or overweight
1 finding from 1 review
Adverse events · children aged 0 to 5 years
1 finding from 1 review
Adverse events (12 (12, 26)) · people with congenital heart disease.
1 finding from 1 review
Adverse events · Children and adolescents with obesity or overweight
1 finding from 1 review
Adverse events related to the use of physical restraints · older people
1 finding from 1 review
Adverse events · adults with non‐advanced colorectal cancer treated surgically or with neoadjuvant or adjuvant therapy, or both
1 finding from 1 review
Adverse events related to taking of blood samples · children aged 6 to 12 years
1 finding from 1 review
Adverse events · participants with quiescent IBD
1 finding from 1 review
Adverse events: · participants with quiescent IBD
1 finding from 1 review
Adverse events: · participants with quiescent IBD
1 finding from 1 review
Adverse events · Children and adolescents with obesity or overweight
1 finding from 1 review
Tolerability ‐ total number of adverse events · adults with long‐term physical conditions (18 years or older)
1 finding from 1 review
Adverse effects (drop‐outs due to adverse effects4) · adults with long‐term physical conditions (18 years or older)
1 finding from 1 review
Adverse events/serious adverse events · people with NMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tolerability ‐ total number of adverse events · adults with long‐term physical conditions (18 years or older)
1 finding from 1 review
acceptability ‐ drop‐outs due to adverse events: post‐intervention · adults with long‐term physical conditions (18 years or older)
It is very uncertain whether pharmacological interventions changes acceptability ‐ drop‐outs due to adverse events: post‐intervention compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · participants with quiescent IBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · participants with quiescent IBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · participants with quiescent IBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found